Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Unconventional role of HMGCS1 in driving pathogenic-Th17 cell immunity and autoimmune diseases

ABSTRACT: Identifying factors controlling pathogenic-Th17 cells is of importance, for their vital role in inflammation and immune-pathology. While intricate ER stress signals have been implicated in T cell biology, its role in Th17 cells remain poorly understood. Here, we demonstrated that HMGCS1, a cholesterol biosynthesis precursor enzyme, was highly induced by inflammatory cytokines and preferentially expressed by pathogenic-Th17 cells in vitro and in vivo. HMGCS1 specifically dictated pathogenic-Th17 cell differentiation and augmented autoimmune diseases. Nonetheless, HMGCS1 role in pathogenic-Th17 cells was independently of cholesterol metabolism but necessitated its catalytic Cys129 residue. Notably, HMGCS1 leveraged IRE1a-XBP1s-dependent ER stress response which was essential for pTh17 cell generation and pathogenicity by transcriptionally activating Rorc loci. Mechanistically, HMGCS1 located to the ER membrane, where it bound and stabilized IRE1a protein via restraining IRE1a interaction with K48-linked ubiquitination-dependent E3 ligase MARCH5. Of note, interfering HMGCS1 and ER stress impeded pathogenic-Th17 immunity and mitigated autoimmune diseases. Therefore, our work reveals a non-canonical axis wherein HMGCS1 sustains ER stress to license pTh17 cell differentiation during autoimmune responses.

ORGANISM(S): Mus musculus

PROVIDER: GSE306371 | GEO | 2026/03/18

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Unconventional role of HMGCS1 in driving pathogenic-Th17 cell immunity and autoimmune diseases II

Project description:Identifying factors controlling pathogenic-Th17 cells is of importance, for their vital role in inflammation and immune-pathology. While intricate ER stress signals have been implicated in T cell biology, its role in Th17 cells remain poorly understood. Here, we demonstrated that HMGCS1, a cholesterol biosynthesis precursor enzyme, was highly induced by inflammatory cytokines and preferentially expressed by pathogenic-Th17 cells in vitro and in vivo. HMGCS1 specifically dictated pathogenic-Th17 cell differentiation and augmented autoimmune diseases. Nonetheless, HMGCS1 role in pathogenic-Th17 cells was independently of cholesterol metabolism but necessitated its catalytic Cys129 residue. Notably, HMGCS1 leveraged IRE1a-XBP1s-dependent ER stress response which was essential for pTh17 cell generation and pathogenicity by transcriptionally activating Rorc loci. Mechanistically, HMGCS1 located to the ER membrane, where it bound and stabilized IRE1a protein via restraining IRE1a interaction with K48-linked ubiquitination-dependent E3 ligase MARCH5. Of note, interfering HMGCS1 and ER stress impeded pathogenic-Th17 immunity and mitigated autoimmune diseases. Therefore, our work reveals a non-canonical axis wherein HMGCS1 sustains ER stress to license pTh17 cell differentiation during autoimmune responses.

2026-03-18 | GSE307331 | GEO

Unconventional role of HMGCS1 in driving pathogenic-Th17 cell immunity and autoimmune diseases [scRNA-seq]

2026-03-18 | GSE306780 | GEO

Unconventional role of HMGCS1 in driving pathogenic-Th17 cell immunity and autoimmune diseases

Project description:Unconventional role of HMGCS1 in driving pathogenic-Th17 cell immunity and autoimmune diseases

| PRJNA1310542 | ENA

Fructose specifically exacerbates pathogenic-Th17 cell differentiation and autoimmune diseases through ROS-EGFR signal

Project description:Th17 cells are quite heterogeneous, with pathogenic roles in autoimmunity and non-pathogenic roles in maintaining tissue homeostasis. Although efforts have been made to study genetic and cellular factors in regulating Th17 cell differentiation, little is known about the role of environmental factors and their underlying mechanisms. Here, we revealed that high-fructose intake selectively enhanced the differentiation and function of IL1b+IL-6+IL-23-induced pathogenic Th17 cells (pTh17), without affecting TGFb1+IL-6-induced non-pTh17 cells, and exacerbated autoimmune diseases models. Notably, fructose enhanced both aerobic glycolysis and OXPHOS activity in pTh17 cells, leading to increased ROS production and subsequently promoting their differentiation. N-acetyl cysteine (NAC), a ROS scavenger, specifically impaired pTh17 cell immunity and mitigated autoimmune disease under high-fructose consumption. Mechanistically, ROS accumulation resulted in higher EGFR expression and activation, which subsequently translocated in nucleus to bind with STAT3, enhancing its transcriptional activity of CNS6 and CNS9 regions of Rorc. Taking together, we illustrated a previously unrecognized mechanism underlying the adverse effects of high-fructose intake in pTh17 cell-related pathologies and diseases.

2025-09-29 | GSE285450 | GEO

Unconventional role of HMGCS1 in driving pathogenic-Th17 cell immunity and autoimmune diseases II

Project description:Unconventional role of HMGCS1 in driving pathogenic-Th17 cell immunity and autoimmune diseases II

| PRJNA1315254 | ENA

Unconventional role of HMGCS1 in driving pathogenic-Th17 cell immunity and autoimmune diseases [scRNA-seq]

Project description:Unconventional role of HMGCS1 in driving pathogenic-Th17 cell immunity and autoimmune diseases [scRNA-seq]

| PRJNA1312097 | ENA

Cytochrome P450 1B1 directs pathogenic-Th17 cell generation and autoimmune disease by maintaining cellular redox homeostasis and mitochondrial function

Project description:Th17 cells are heterogenous. Pathogenic Th17 cells induced by IL-23, have been well implicated in inflammatory bowel disease (IBD), while the underlying mechanisms remain unclear. Here, we revealed that cytochrome P450 1B1 (CYP1B1) is specifically upregulated in mice and human colitis disease. With CYP1B1 knockout mice, we found that CYP1B1 specifically promoted IL-6+IL-1b+IL-23 induced pathogenic-Th17 cells while has no effect on TGFb1+IL-6-induced homeostatic Th17 cells. CYP1B1 deficiency significantly ameliorated disease severity in both DSS-induced colitis and colitis-associated colorectal cancer (CAC) models, and impaired pTh17 responses in vivo. Additionally, CYP1B1 deficiency in T cells disrupted glutathione/ROS homeostasis, leading mitochondrial dysfunction and apoptosis by pTh17 cells. ROS elimination by NAC or ectopically GSS expression increased mitochondria fitness and promoted pTh17 cell generation. Taking together, our findings uncover a CYP1B1-ROS-mitochonrial axis in driving pTh17 cell generation and proinflammatory function, interfering this hub may be benefit for pTh17 cell-related immunopathology.

2026-02-02 | GSE302396 | GEO

Expression data from in vitro polarized-pathogenic Th17 system transfected with YY1 shRNA lentivirus

Project description:The proportion of pathogenic Th17 (pTh17) cells were significantly higher in RA than that in control individuals and showed a potential relevance with YY1 expression. Increased YY1 expression was observed in pTh17, and the pTh17 differentiation was hampered by YY1 knockdown. We used microarrays to detail the gene expression changes of pTh17 transfected with YY1 shRNA lentivirus and tried to elucidate the potential mechanisms how YY1 can affect pTh17 cell differentiation in RA.

2021-09-30 | GSE184979 | GEO

RPL6 interacts with HMGCS1 to stabilize HIF-1α by activating cholesterol biosynthesis in hepatocellular carcinoma

Project description:The identification of predictive markers to determine the premetastatic phase before metastasis is critical for developing effective strategies for early detection and prevention. By applying the dynamic network biomarker (DNB) approach to analyze time-series transcriptomic data from a pulmonary metastasis HCC mouse model, we revealed that the premetastatic phase occurred during the fourth week after implantation. A total of 142 DNB genes were identified as functionally important biomarkers of this critical phase, among which 60S ribosomal protein L6 (RPL6) was a core DNB member. RPL6 was significantly upregulated in HCC tissues with extrahepatic metastasis and was strongly correlated with poor prognosis in HCC patients. RPL6 promoted the invasion and metastasis of HCC cells, both in vitro and in vivo. Mechanistically, RPL6 directly bound to the HMGCS1 mRNA 3’UTR, a rate-limiting enzyme in cholesterol biosynthesis, thus increasing HMGCS1 mRNA stability and protein expression and subsequently elevating intracellular cholesterol level. Elevated cholesterol inhibited of the ubiquitin-dependent degradation of HIF-1α by binding to PHD2 and reducing PHD2-mediated hydroxylation of HIF-1α, which further resulted in HIF-1α signaling pathway activation. Moreover, RPL6, HMGCS1 and HIF-1α were coexpressed in HCC tissues with extrahepatic metastasis. Taken together, this study provides new insights into the dynamic transcriptome profiles of HCC pulmonary metastasis and establishes an important role for the RPL6-HMGCS1-HIF-1α axis in HCC metastasis, suggesting potential prognostic biomarkers and therapeutic targets in HCC.

2025-12-02 | GSE274574 | GEO